![Max Rosett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max Rosett
Direttore Finanziario/CFO presso
IMMUNOME, INC.
Patrimonio netto: 2 M $ in data 31/07/2026
Profilo
Max Rosett currently works at Immunome, Inc. as CFO, Chief Accounting Officer & EVP-Operations since 2024.
Formerly, Mr. Rosett was Chief Operating Officer at MorphImmune, Inc. from 2022 to 2023 and Principal at Research Bridge Partners from 2021 to 2023.
Mr. Rosett completed graduate education at Georgia Institute of Technology in 2016 and undergraduate education at Yale University in 2012.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMUNOME, INC. 0,09% | 23/07/2026 | 101.287 ( 0,09% ) | 2 M $ | 31/07/2026 |
Posizioni attive di Max Rosett
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOME, INC. | Direttore Finanziario/CFO | 02/01/2024 |
Precedenti posizioni note di Max Rosett
| Società | Posizione | Fine |
|---|---|---|
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Corporate Officer/Principal | 01/11/2023 |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Direttore operativo | 01/10/2023 |
Formazione di Max Rosett
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners invests in companies located in the United States. The firm focuses on a biomedical sector. It provides finance for seed stage capital requirements. | Finance |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
